Showing results (21-30 of 315) with videos related to

Sort By:
Pageof 32
European Journal of Applied Physiology|August 28, 2013
Meal induced gut hormone secretion is altered in aerobically trained compared to sedentary young healthy malesMichael Taulo Lund, Lærke Taudorf, Bolette Hartmann, et al.
BMC Endocrine Disorders|September 6, 2018
No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic courseKristian H Mikkelsen, Tina Vilsbøll, Jens J Holst, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2014
Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome modelRyo Sueyoshi, Kathleen M Woods Ignatoski, Manabu Okawada, et al.
Bone|June 21, 2021
Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary studyKirsa Skov-Jeppesen, Simon Veedfald, Sten Madsbad, et al.
The Journal of Clinical Endocrinology and Metabolism|October 8, 2015
Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy ExpenditureJonatan Ising Bagger, Jens Juul Holst, Bolette Hartmann, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 23, 2015
Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influxRune Ehrenreich Kuhre, Louise Ellegaard Bechmann, Nicolai Jacob Wewer Albrechtsen, et al.
Journal of Diabetes and Its Complications|January 28, 2015
Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptideRune Ehrenreich Kuhre, Nicolai Jacob Wewer Albrechtsen, Bolette Hartmann, et al.
Regulatory Peptides|March 23, 2011
The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patientsLasse Bremholm, Mads Hornum, Ulrik B Andersen, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2005
Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YYPeter T Schmidt, Tryggve Ljung, Bolette Hartmann, et al.
Peptides|February 4, 2014
GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell linesRune Ehrenreich Kuhre, Nicolai Wewer Albrechtsen, Johanne Agerlin Windeløv, et al.
Pageof 32